ArticleAlimentary pharmacology & therapeutics2021

Editorial: anti-TNF agents against vedolizumab as a second-line treatment? Not surprising tie game.

Xavier Roblin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.